Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Bio-Techne Surges on $73-Per-Share Cash Takeover Agreement

None

Bio-Techne (TECH) is up 19.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The sharp move appears tied to a definitive agreement for Merck KGaA, Darmstadt, Germany to acquire Bio-Techne for $73 per share in cash. A buyout at a premium often pulls a stock quickly toward the deal price, which likely explains most of today’s gain.

Details:

  • Bio-Techne entered into a definitive agreement to be acquired in an all-cash transaction priced at $73 per share.
  • The deal values the company at about $11.3 billion and was presented as a strategic expansion of the buyer’s life sciences business.
  • The offer price was described as a 36% premium to Bio-Techne’s one-month volume-weighted average trading price, giving investors a clear valuation anchor.
  • The transaction is expected to close in late 2026 or early 2027, subject to shareholder approval and customary regulatory clearances.
  • Sources:

    PR Newswire, Investing.com, Nasdaq

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $TECH Insider Trading Activity

    TECH Insider Trades

    $TECH insiders have traded $TECH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $TECH stock by insiders over the last 6 months:

    • AMY E. HERR sold 1,976 shares for an estimated $116,791

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive TECH Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $TECH Hedge Fund Activity

    We have seen 259 institutional investors add shares of $TECH stock to their portfolio, and 347 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $TECH Congressional Stock Trading

    Members of Congress have traded $TECH stock 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

    Here’s a breakdown of recent trading of $TECH stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $TECH Price Targets

    Multiple analysts have issued price targets for $TECH recently. We have seen 8 analysts offer price targets for $TECH in the last 6 months, with a median target of $65.0.

    Here are some recent targets:

    • David Westenberg from Piper Sandler set a target price of $65.0 on 06/11/2026
    • Dan Leonard from RBC Capital set a target price of $62.0 on 05/15/2026
    • Brandon Couillard from Wells Fargo set a target price of $62.0 on 05/07/2026
    • Daniel Markowitz from Evercore ISI Group set a target price of $50.0 on 05/07/2026
    • Patrick Donnelly from Citigroup set a target price of $70.0 on 05/07/2026
    • Kyle Boucher from TD Cowen set a target price of $80.0 on 02/05/2026
    • Dan Leonard from UBS set a target price of $79.0 on 02/05/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles